Home › Funds › SurgoCap Partners LP › MDLN
SurgoCap Partners LP position in MDLN
MEDLINE INC · Health Care
SurgoCap Partners LP reported holding 6,575,970 shares of MDLN (MEDLINE INC) in its Q3 2026 13F filing — a position valued at US$228.2M, representing 7.50% of its reported portfolio and ranking #7 among its reported holdings. SurgoCap Partners LP has disclosed MDLN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How SurgoCap Partners LP's MDLN position evolved
SurgoCap Partners LP first disclosed a stake in MDLN in Q1 2026 at 6,075,165 shares (US$270.3M). The position peaked in Q2 2026 at 7,487,507 shares, worth US$295.3M. Across 3 filings, SurgoCap Partners LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,575,970 shares valued at US$228.2M — a reduction of -911,537 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 6.08M | $270.34M | New |
| Q2 2026 | 7.49M | $295.31M | Add |
| Q3 2026 | 6.58M | $228.19M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MDLN and 13F data
MDLN (MEDLINE INC) is a Health Care company. 86 other funds we track also report a position in MDLN — the largest reported positions include Carlyle Group Inc. (US$6.49B), Blackstone Inc. (US$4.01B), H&F Corporate Investors X, Ltd. (US$2.46B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MDLN
- Carlyle Group Inc. 187.08M sh · $6.49B · Q3 2026
- Blackstone Inc. 101.79M sh · $4.01B · Q2 2026
- H&F Corporate Investors X, Ltd. 70.87M sh · $2.46B · Q3 2026
- Lone Pine Capital 20.97M sh · $826.99M · Q2 2026
- LONE PINE CAPITAL LLC 20.97M sh · $826.99M · Q2 2026
- Egerton Capital (UK) LLP 13.28M sh · $460.92M · Q3 2026
- Alyeska Investment Group, L.P. 6.81M sh · $268.55M · Q2 2026
- BANQUE PICTET & CIE SA 7.46M sh · $258.69M · Q3 2026
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 7.02M sh · $243.56M · Q3 2026
- Unisphere Establishment 3.68M sh · $145.24M · Q2 2026
- Durable Capital Partners LP 2.63M sh · $103.62M · Q2 2026
- EMINENCE CAPITAL, LP 2.28M sh · $101.42M · Q1 2026
More on SurgoCap Partners LP
FAQ
How long has SurgoCap Partners LP held MDLN?
SurgoCap Partners LP has disclosed MDLN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is SurgoCap Partners LP's current position in MDLN?
As of Q3 2026, SurgoCap Partners LP holds 6.58M shares of MDLN (MEDLINE INC), valued at $228.19M, representing 7.50% of its reported portfolio and ranking #7.
Has SurgoCap Partners LP been buying or selling MDLN?
In the latest 13F filing (Q3 2026), SurgoCap Partners LP reduced its position in MDLN. The position peaked in Q2 2026 at 7.49M shares.
Which other funds hold MDLN?
Other major institutional holders of MDLN include Carlyle Group Inc., Blackstone Inc., H&F Corporate Investors X, Ltd., among 86 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.